LRRK2 and Parkinson disease: Functionally, CDGI enhances LRRK2's GTP‐binding capacity, membrane association, and kinase activity (evidenced by increased Rab10 phosphorylation—effects amplified by calcium signaling, implicating calcium dyshomeostasis in LRRK2‐linked PD pathogenesis.